‎“Al Hammadi” increases capital of a subsidiary company to 173 ‎million riyals

Al Hammadi Holding Company announced the approval of the Extraordinary General Assembly of Sudair Pharmaceuticals (one of the sister companies of Al Hammadi Holding, which is 35% owned), to increase its capital from 57 million riyals to 173 million riyals, by 116 million riyals.

According to the announcement published on Tadawul, the company’s capital will be increased by transferring from the partners’ current balance according to the capital ratio of each partner.

With this increase, the company aims to support its financial position in addition to growing its activity and developing its business.